The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / WHO Warns of Widespread Misunderstanding of Superbug Threat

WHO Warns of Widespread Misunderstanding of Superbug Threat

November 17, 2015 • By Kate Kelland

  • Tweet
  • Email
Print-Friendly Version / Save PDF

LONDON (Reuters)—People across the world are confused about the major threat to public health posed by drug-resistant superbugs and do not know how to stop that risk growing, the World Health Organization (WHO) said on Monday.

You Might Also Like
  • FDA Warns Makers of Superbug-Prone Scopes over Testing Violations
  • Scientists Find How ‘Superbugs’ Build Their Defenses
  • 37,000 U.S. Infection-Related Deaths Preventable Over 5 Years

Ramping up its fight against antibiotic resistance with a survey of public awareness, the United Nations health agency said 64% of those asked believed wrongly that penicillin-based drugs and other antibiotics can treat colds and flu, despite the fact such medicines have no impact on viruses.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Around a third of people surveyed also wrongly believed they should stop taking antibiotics when they feel better, rather than completing the prescribed treatment course, the WHO said.

“The findings … point to the urgent need to improve understanding around antibiotic resistance,” said Keiji Fukuda, the WHO’s special representative for antimicrobial resistance.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“One of the biggest health challenges of the 21st century will require global behavior change by individuals and societies.”

Over-use and misuse of antibiotics are the drivers of antibiotic resistance. Superbug infections—including multi-drug-resistant forms of tuberculosis, typhoid and gonorrhea—kill hundreds of thousands of people a year, and the trend is growing.

“The rise of antibiotic resistance is a global health crisis,” the WHO’s director-general Margaret Chan said in a statement. “It is reaching dangerously high levels in all parts of the world.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The WHO surveyed 10,000 people across 12 countries—Barbados, China, Egypt, India, Indonesia, Mexico, Nigeria, Russia, Serbia, South Africa, Sudan and Vietnam—and found many worrying misconceptions.

Three quarters of respondents wrongly think antibiotic resistance means the body is resistant to the drugs.

Some 66% believe individuals are not at risk of a drug-resistant infection if they personally take their antibiotics as prescribed. An equal number thinks antibiotics can be used to treat viral infections and one third think they can stop taking antibiotics when they feel better rather than taking the full course, a practice that contributes to antibiotic resistance.

The WHO survey was released today to coincide with the first World Antibiotic Awareness Week, Nov. 16–22.

The WHO has launched a campaign, “Antibiotics: Handle With Care,” to increase awareness of global antibiotic resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of antibiotic resistance.

Filed Under: Drug Updates, Safety Tagged With: antibiotics, drug-resistant superbug, International, World Health Organization

You Might Also Like:
  • FDA Warns Makers of Superbug-Prone Scopes over Testing Violations
  • Scientists Find How ‘Superbugs’ Build Their Defenses
  • 37,000 U.S. Infection-Related Deaths Preventable Over 5 Years
  • FDA Warns of Severe Joint Pain Risk with DPP-4 Diabetes Drugs

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)